ASX - By Stock
|
AGN |
Re:
Ann: Patient Dosing Milestone Achieved in Phase 2 Stroke Trial
|
|
nombre
|
3 |
1.1K |
4 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
3
|
1.1K
|
4
|
|
ASX - By Stock
|
RAC Biotech |
Re:
Large BUY - ex insider/ ex CSO / new consultant - Dr Tillett
|
|
nombre
|
143 |
53K |
20 |
31/08/23 |
31/08/23 |
ASX - By Stock
|
143
|
53K
|
20
|
|
ASX - By Stock
|
MQR |
Re:
Ann: Kibby Basin Lithium Project Update
|
|
nombre
|
150 |
50K |
10 |
14/11/22 |
14/11/22 |
ASX - By Stock
|
150
|
50K
|
10
|
|
ASX - By Stock
|
KDY |
Re:
Ann: Management Change
|
|
nombre
|
445 |
123K |
6 |
11/10/22 |
11/10/22 |
ASX - By Stock
|
445
|
123K
|
6
|
|
ASX - By Stock
|
KDY |
Re:
Ann: DW8 Secures Institutional Funding Launches Entitlement Offer
|
|
nombre
|
413 |
122K |
4 |
21/09/22 |
21/09/22 |
ASX - By Stock
|
413
|
122K
|
4
|
|
ASX - By Stock
|
KDY |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
nombre
|
185 |
54K |
5 |
01/08/22 |
01/08/22 |
ASX - By Stock
|
185
|
54K
|
5
|
|
ASX - By Stock
|
KDY |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
nombre
|
185 |
54K |
6 |
29/07/22 |
29/07/22 |
ASX - By Stock
|
185
|
54K
|
6
|
|
ASX - By Stock
|
KDY |
Re:
DW8 Growth
|
|
nombre
|
16K |
5.2M |
2 |
19/05/22 |
19/05/22 |
ASX - By Stock
|
16K
|
5.2M
|
2
|
|
ASX - By Stock
|
MQR |
Re:
Ann: Becoming a substantial holder
|
|
nombre
|
12 |
5.6K |
3 |
21/04/22 |
21/04/22 |
ASX - By Stock
|
12
|
5.6K
|
3
|
|
ASX - By Stock
|
RAC |
Re:
Ann: MD Anderson Preclinical AML Study on Zantrene Published
|
|
nombre
|
54 |
19K |
7 |
26/02/22 |
26/02/22 |
ASX - By Stock
|
54
|
19K
|
7
|
|
ASX - By Stock
|
RAC |
Re:
Ann: MD Anderson Preclinical AML Study on Zantrene Published
|
|
nombre
|
54 |
19K |
10 |
25/02/22 |
25/02/22 |
ASX - By Stock
|
54
|
19K
|
10
|
|
ASX - By Stock
|
MQR |
Re:
Ann: OUTSTANDING HIGH GRADE COPPER GOLD ASSAYS -LONE STAR PROJECT
|
|
nombre
|
425 |
106K |
5 |
07/01/22 |
07/01/22 |
ASX - By Stock
|
425
|
106K
|
5
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Oncology Share Purchase Plan Opens
|
|
nombre
|
557 |
165K |
16 |
26/11/21 |
26/11/21 |
ASX - By Stock
|
557
|
165K
|
16
|
|
ASX - By Stock
|
KDY |
Re:
DW8 Growth
|
|
nombre
|
16K |
5.2M |
3 |
23/11/21 |
23/11/21 |
ASX - By Stock
|
16K
|
5.2M
|
3
|
|
ASX - By Stock
|
KDY |
Re:
Ann: Completion of Share Purchase Plan
|
|
nombre
|
31 |
9.7K |
2 |
07/11/21 |
07/11/21 |
ASX - By Stock
|
31
|
9.7K
|
2
|
|
ASX - By Stock
|
KDY |
Re:
Ann: Completion of Share Purchase Plan
|
|
nombre
|
31 |
9.7K |
1 |
05/11/21 |
05/11/21 |
ASX - By Stock
|
31
|
9.7K
|
1
|
|
ASX - By Stock
|
KDY |
Re:
Ann: Trading Halt
|
|
nombre
|
237 |
80K |
3 |
13/10/21 |
13/10/21 |
ASX - By Stock
|
237
|
80K
|
3
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
nombre
|
22K |
7.9M |
19 |
06/10/21 |
06/10/21 |
ASX - By Stock
|
22K
|
7.9M
|
19
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
nombre
|
22K |
7.9M |
22 |
27/05/21 |
27/05/21 |
ASX - By Stock
|
22K
|
7.9M
|
22
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
nombre
|
22K |
7.9M |
28 |
02/04/21 |
02/04/21 |
ASX - By Stock
|
22K
|
7.9M
|
28
|
|
ASX - By Stock
|
KDY |
Re:
Option Valuation and Opportunity Costs
|
|
nombre
|
108 |
33K |
2 |
26/03/21 |
26/03/21 |
ASX - By Stock
|
108
|
33K
|
2
|
|